The Gastrointestinal Endoscopy Market Size is valued at USD 15.30 billion in 2023 and is predicted to reach USD 23.36 billion by the year 2031 at a 5.64 % CAGR during the forecast period for 2024-2031.
Key Industry Insights & Findings from the Report:
- The market is driven by major factors such as the increasing prevalence of gastrointestinal diseases.
- Growing focus of hospitals to invest in technologically advanced endoscopy instruments and expand endoscopy units, driving the gastrointestinal endoscopy market.
- North America dominated the market and accounted for a global revenue share in 2023.
- A key challenge for the gastrointestinal endoscopy market is the lack of skilled healthcare professionals, particularly trained endoscopists.
A gastrointestinal endoscopy, also known as gastroscopy or digestive endoscopy, is a diagnostic and therapeutic procedure for illnesses of the upper digestive tract. The oesophagus, stomach, and duodenum form the upper digestive system (the first part of the small intestine). The endoscope device is introduced through the mouth, and the acquired images are presented on the monitor in real-time and/or recorded as the endoscope moves through the body. Endoscopy is occasionally performed with other procedures, such as an ultrasound. Attaching an ultrasound probe to the endoscope creates images of the oesophagus or stomach wall. Endoscopic ultrasound can also be used to create images of inaccessible organs, such as the pancreatic. Newer endoscopes utilise high-definition video to provide images with greater clarity. Numerous endoscopes employ a narrow band imaging technology that uses specialised light to improve the detection of precancerous diseases like Barrett's oesophagus. Modern endoscopy has shown to be immensely valuable in many fields of medicine because it entails relatively few risks, produces detailed images, and is rapid to do.
The gastrointestinal endoscopy market will be driven by factors such as an increasing need for endoscopy, the progress of new technologies, an increase in investments and funding, an increasing number of cases of gastrGlobal Gastrointestinal Endoscopy Market ointestinal illnesses, and increasing demand for procedures that are minimally invasive. Also, new device approvals will play an essential role in developing gastrointestinal endoscopy. In Feb 2022, Ambu announced that the FDA had approved their Ambu® aScopeTM Gastro and Ambu® aBoxTM 2 Single-Use Gastroscope and Next-Generation Display Unit. Ambu's solution addresses the current drawbacks of reusable endoscopes with advanced technology, portability, and cost-effectiveness, making it a suitable alternative for customers looking to perform gastroscopies in a variety of care settings (including endoscopy unit, OR, ICU, ER, ASC).
However, the high cost of endoscopic operations, adverse healthcare development, and limited reimbursement will hinder the growth of the market for gastrointestinal endoscopy. However, the expanding healthcare market in emerging nations and the development of gastrointestinal endoscopic devices will create several growth prospects for the gastrointestinal endoscopy market throughout the forecasting period.
Competitive Landscape
Some major key players in the Gastrointestinal Endoscopy Market:
- Boston Scientific Corporation,
- Medtronic plc,
- KARL STORZ SE & Co. KG,
- Ambu A/S,
- Teleflex Incorporated,
- HOYA Corporation,
- Olympus Corporation,
- FUJIFILM Holdings Corporation,
- Cook Group Inc,
- SonoScape Medical Corp.,
- EndoMed Systems GmbH,
- CapsoVision, Inc.,
- HuiZhou Xzing Technology Co., Ltd.,
- Endogene Ltd.,
- Envaste Limited
Market Segmentation
The Gastrointestinal Endoscopy Market is segmented into two major segments Types and End-User. By type, the market is widely classified. First is Gastrointestinal Endotherapy, which includes ERCP Devices, Gastrointestinal Stents, Balloon Dilators, Ultrasound Endoscopes, Biopsy Devices, Hemostasis Devices, Retrieval Devices, and Others. The gastrointestinal Stents category is subdivided into Esophageal Stents, Biliary Stents, and Pancreatic Stents. In comparison, the Biopsy Devices category is again divided into Biopsy Forceps, Polypectomy Snares, and Other Biopsy Devices. The second is Gastrointestinal Endoscopes and Endoscopic Systems, which contains three sub-divisions: Gastrointestinal Videoscopes, Visualization Systems, and Capsule Endoscopes. The sub-division Gastrointestinal Videoscopes comprises Gastroscopes, Colonoscopes, Duodenoscopes, Sigmoidoscopes, Enteroscopes and Anoscopes. The second significant segment, the End-User segment, includes, Hospitals, Ambulatory Surgery Centers, and Others.
In 2021, North America dominated the market. The introduction of new endoscopic devices will fuel market growth in North America. In addition, the increased prevalence of gastrointestinal illnesses, cancer, and other chronic conditions, as well as the rising desire for minimally invasive procedures, will increase North America's global market share.
Recent Developments:
- In April 2024, Medtronic plc, a healthcare technology leader, introduced ColonPRO™, the latest AI software for its GI Genius™ intelligent endoscopy system, with the goal of improving patient care through strategic collaboration.
Gastrointestinal Endoscopy Market Report Scope
|
Report Attribute |
Specifications |
|
Market size value in 2023 |
USD 15.30 Bn |
|
Revenue forecast in 2031 |
USD 23.36 Bn |
|
Growth rate CAGR |
CAGR of 5.64 % from 2024 to 2031 |
|
Quantitative units |
Representation of revenue in US$ Million and CAGR from 2024 to 2031 |
|
Historic Year |
2019 to 2023 |
|
Forecast Year |
2024-2031 |
|
Report coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments covered |
By Type and End-User |
|
Regional scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ; France; Italy; Spain; South Korea; South East Asia |
|
Competitive Landscape |
Boston Scientific Corporation, Medtronic plc, KARL STORZ SE & Co. KG, Ambu A/S, Teleflex Incorporated, HOYA Corporation, Olympus Corporation, FUJIFILM Holdings Corporation, Cook Group Inc, SonoScape Medical Corp., EndoMed Systems GmbH, CapsoVision, Inc., HuiZhou Xzing Technology Co., Ltd., Endogene Ltd., Envaste Limited |
|
Customization scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing and available payment methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Corporate
Office :
Office No.5170, 5th Floor Marvel Fuego, Magarpatta Rd, Pune, 411028
info@insightaceanalytic.com
